KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Minority Interest (2023 - 2025)

Boston Scientific's Minority Interest history spans 3 years, with the latest figure at $239.0 million for Q4 2025.

  • For Q4 2025, Minority Interest rose 2.58% year-over-year to $239.0 million; the TTM value through Dec 2025 reached $239.0 million, up 2.58%, while the annual FY2025 figure was $239.0 million, 2.58% up from the prior year.
  • Minority Interest for Q4 2025 was $239.0 million at Boston Scientific, up from $233.0 million in the prior quarter.
  • Across five years, Minority Interest topped out at $259.0 million in Q1 2023 and bottomed at $233.0 million in Q4 2024.
  • The 3-year median for Minority Interest is $241.0 million (2023), against an average of $243.3 million.
  • The largest annual shift saw Minority Interest decreased 6.05% in 2024 before it grew 2.58% in 2025.
  • A 3-year view of Minority Interest shows it stood at $248.0 million in 2023, then dropped by 6.05% to $233.0 million in 2024, then increased by 2.58% to $239.0 million in 2025.
  • Per Business Quant, the three most recent readings for BSX's Minority Interest are $239.0 million (Q4 2025), $233.0 million (Q4 2024), and $238.0 million (Q2 2024).